New TB vaccines: is there a requirement for CD8 T cells?

  • W Henry Boom
  • Published 2007 in The Journal of clinical investigation


MHC class I-restricted CD8(+) T cells are necessary to mount an immune response against Mycobacterium tuberculosis. M. tuberculosis antigens can enter MHC class I cross-processing pathways through a number of different mechanisms, including via the uptake of antigen-containing apoptotic vesicles released by infected cells. A study in this issue of the JCI by Hinchey and colleagues shows that M. tuberculosis inhibits host cell apoptosis and thus may interfere with optimal cross-priming and action of CD8(+) T cells (see the related article beginning on page 2279). M. tuberculosis genetically modified to induce apoptosis is shown to be more effective in priming CD8(+) T cells in vivo and therefore may be a more effective vaccine against tuberculosis than the currently utilized M. bovis BCG vaccine.

1 Figure or Table


Citations per Year

91 Citations

Semantic Scholar estimates that this publication has 91 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Boom2007NewTV, title={New TB vaccines: is there a requirement for CD8 T cells?}, author={W Henry Boom}, journal={The Journal of clinical investigation}, year={2007}, volume={117 8}, pages={2092-4} }